• Isaure de Boisriou, Sami Ellouze, Christian Kassasseya, Anne-Laure Feral-Pierssens, Camille Gerlier, Anthony Chauvin, Sebastien Beaune, Evelyne Dubreucq, Laurent Pereira, Richard Chocron, Mehdi Khellaf, Éric Mariotte, Lara Zafrani, and Olivier Peyrony.
• Nantes University, Nantes, France.
• Intern Emerg Med. 2024 Jan 1; 19 (1): 115124115-124.

AbstractTo estimate the rate of inappropriate diagnosis in patients who visited the ED with thrombotic microangiopathy (TMA) and to assess the factors and outcomes associated with emergency department (ED) misdiagnosis. Retrospective multicenter study of adult patients admitted to the intensive care unit (ICU) for TMA from 2012 to 2021 who had previously attended the ED for a reason related to TMA. Patient characteristics and outcomes were compared in a univariate analysis based on whether a TMA diagnosis was mentioned in the ED or not. Forty patients were included. The diagnosis of TMA was not mentioned in the ED in 16 patients (40%). Patients for whom the diagnosis was mentioned in the ED had more frequently a request for schistocytes research, and therefore had more often objectified schistocytes. They also had more frequently a troponin dosage in the ED (even if the difference was not significant), an ECG performed or interpreted, and were admitted more quickly in the ICU (0 [0-0] vs 2 [0-2] days; P = 0.002). Hemoglobin levels decreased significantly in both groups, and creatinine levels increased significantly in the misdiagnosis group between ED arrival and ICU admission. In patients with a final diagnosis of TTP, the time to platelets durable recovery was shorter for those in whom the diagnosis was mentioned in the ED without reaching statistical significance (7 [5-11] vs 14 [5-21] days; P = 0.3).© 2023. The Author(s), under exclusive licence to Società Italiana di Medicina Interna (SIMI).

14 keywords...

hide…